Does DSIP actually help you sleep?

The older literature is genuinely mixed — some small studies reported effects, others none. No modern controlled trials settle it, and no sleep-medicine guideline includes it.

The peptide occurs naturally in the body. As always, that says nothing about whether injecting a synthetic version from an unregulated source is safe or useful.

Why hasn't DSIP become a sleep drug?

Half a century after its discovery, the effect never proved robust enough to carry a drug-development program — which is itself a data point about the strength of the signal.

DSIP (Delta Sleep-Inducing Peptide)

Research-stage — not approved for human useEvidence: Mostly animal/lab studiesSleep & Relaxation

Delta sleep-inducing peptide; an endogenous peptide studied in older literature, not FDA-approved.

Profile last verified 2026-08-20

What it is

Delta sleep-inducing peptide is a naturally occurring peptide first isolated in the 1970s from studies of sleep physiology. The name oversells it: subsequent research on whether administering DSIP actually improves sleep produced decades of mixed, mostly older, mostly small studies.

It was never developed into an approved drug, and modern sleep medicine does not use it. Online sellers lean entirely on the evocative name and the vintage literature.

What researchers have actually studied it for

Sleep physiology in older research literature, with inconsistent findings; never developed into an approved therapy.

How it works

Genuinely unclear — half a century on, DSIP has no confirmed receptor. Proposed involvement spans sleep-regulatory circuits, stress-axis modulation and opioid-adjacent signaling, but the molecule's mechanism remains one of sleep science's loose ends, which suits its inconsistent effects.

Where it came from

Swiss researchers isolated it in 1974 from the blood of sleeping rabbits — a genuinely elegant experiment — and named it for the delta-wave sleep it seemed to induce. Decades of follow-up produced conflicting results, the field moved on to orexin and GABA pharmacology, and DSIP became a historical footnote the gray market later revived.

What the research record actually contains

1970s–80s animal and small human studies with inconsistent sleep effects.
Scattered explorations in pain and withdrawal, none conclusive.
No modern controlled trials; no presence in sleep-medicine guidelines.

What's known about risks

Old studies reported little acute toxicity; that is not a modern safety file. With no confirmed mechanism and no contemporary data, its risk profile is simply unwritten.

Where it stands legally

Never approved anywhere; research-chemical channel only.

Worth asking a licensed provider

1.Have we actually worked up my sleep problem — apnea screening, sleep hygiene, CBT-I?
2.Why would a compound abandoned by sleep science help where evaluated treatments haven't been tried?
3.What proven options fit my specific sleep complaint?